Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Braunlin

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Plos Currents|January 25, 2014
A randomized, double-blind trial of lisinopril and losartan for the treatment of cardiomyopathy in duchenne muscular dystrophyHugh D Allen, Kevin M Flanigan, Philip T Thrush, et al.
Molecular Therapy. Methods & Clinical Development|December 17, 2024
Intrathecal or intravenous AAV9-IDUA/RGX-111 at minimal effective dose prevents cardiac, skeletal and neurologic manifestations of murine MPS ILalitha R Belur, Avery K Huber, Hillary Mantone, et al.
Orphanet Journal of Rare Diseases|June 15, 2019
Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidanceMehmet Umut Akyol, Tord D Alden, Hernan Amartino, et al.
Orphanet Journal of Rare Diseases|May 31, 2019
Recommendations for the management of MPS VI: systematic evidence- and consensus-based guidanceMehmet Umut Akyol, Tord D Alden, Hernan Amartino, et al.
The Canadian Journal of Cardiology|December 2, 2024
Factors Associated With Shock at Presentation in Kawasaki Disease Versus Multisystem Inflammatory Syndrome in Children Associated With Covid-19Supriya S Jain, Ashraf S Harahsheh, Simon Lee, et al.
Pediatric Cardiology|May 12, 2025
Systemic Arterial Aneurysms in Kawasaki Disease: An Important Evidence GapWilliam B Orr, Marianna Fabi, Michael Khoury, et al.
American Heart Journal|June 2, 2020
Expanding the clinical and genetic spectrum of ALPK3 variants: Phenotypes identified in pediatric cardiomyopathy patients and adults with heterozygous variantsJohanna C Herkert, Judith M A Verhagen, Raquel Yotti, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Plos Currents|January 25, 2014
A randomized, double-blind trial of lisinopril and losartan for the treatment of cardiomyopathy in duchenne muscular dystrophyHugh D Allen, Kevin M Flanigan, Philip T Thrush, et al.
Molecular Therapy. Methods & Clinical Development|December 17, 2024
Intrathecal or intravenous AAV9-IDUA/RGX-111 at minimal effective dose prevents cardiac, skeletal and neurologic manifestations of murine MPS ILalitha R Belur, Avery K Huber, Hillary Mantone, et al.
Orphanet Journal of Rare Diseases|June 15, 2019
Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidanceMehmet Umut Akyol, Tord D Alden, Hernan Amartino, et al.
Orphanet Journal of Rare Diseases|May 31, 2019
Recommendations for the management of MPS VI: systematic evidence- and consensus-based guidanceMehmet Umut Akyol, Tord D Alden, Hernan Amartino, et al.
The Canadian Journal of Cardiology|December 2, 2024
Factors Associated With Shock at Presentation in Kawasaki Disease Versus Multisystem Inflammatory Syndrome in Children Associated With Covid-19Supriya S Jain, Ashraf S Harahsheh, Simon Lee, et al.
Pediatric Cardiology|May 12, 2025
Systemic Arterial Aneurysms in Kawasaki Disease: An Important Evidence GapWilliam B Orr, Marianna Fabi, Michael Khoury, et al.
American Heart Journal|June 2, 2020
Expanding the clinical and genetic spectrum of ALPK3 variants: Phenotypes identified in pediatric cardiomyopathy patients and adults with heterozygous variantsJohanna C Herkert, Judith M A Verhagen, Raquel Yotti, et al.
Pageof 4